Tonix Pharmaceuticals Holding Corp. Contracts & Agreements

Description of Registrants Securities (Filed With SEC on April 1, 2024)

Placement Agent Agreement, dated March 28, 2024, between Tonix Pharmaceuticals Holding Corp. and A.G.P./Alliance Global Partners (Filed With SEC on March 29, 2024)

Form of Pre-Funded Warrant (Filed With SEC on March 29, 2024)

Form of Series E Warrant (Filed With SEC on March 29, 2024)

Form of Securities Purchase Agreement (Filed With SEC on March 29, 2024)

Form of Warrant Amendment Agreement (Filed With SEC on March 29, 2024)

Placement Agent Agreement, dated December 20, 2023, between Tonix Pharmaceuticals Holding Corp. and A.G.P./Alliance Global Partners (Filed With SEC on December 21, 2023)

Form of Pre-Funded Warrant (Filed With SEC on December 21, 2023)

Form of Series C Warrant (Filed With SEC on December 21, 2023)

Form of Series D Warrant (Filed With SEC on December 21, 2023)

Form of Securities Purchase Agreement (Filed With SEC on December 21, 2023)

Loan and Guaranty Agreement, dated as of December 8, 2023, by and among the Loan Parties, the Lenders and the JGB Agent (Filed With SEC on December 8, 2023)

Placement Agent Agreement, dated September 28, 2023, among Tonix Pharmaceuticals Holding Corp., A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of... (Filed With SEC on September 29, 2023)

Placement Agent Agreement, dated July 27, 2023, among Tonix Pharmaceuticals Holding Corp., A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia... (Filed With SEC on July 28, 2023)

TRANSITION SERVICES AGREEMENT (Filed With SEC on July 3, 2023)

Asset Purchase Agreement, dated as of June 23, 2023, by and among Upsher-Smith Laboratories, LLC, Tonix Medicines, Inc. and Tonix Pharmaceuticals Holding Corp. Press Release of... (Filed With SEC on June 26, 2023)

Description of Registrants Securities (Filed With SEC on March 13, 2023)

Form of Securities Purchase Agreement between Tonix Pharmaceuticals Holding Corp. and the investors thereto, dated October 25, 2022 (Filed With SEC on October 25, 2022)

Form of Registration Rights Agreement between Tonix Pharmaceuticals Holding Corp. and the investors thereto, dated October 25, 2022 (Filed With SEC on October 25, 2022)

Form of Side Letter between Tonix Pharmaceuticals Holding Corp. and each investor, dated October 25, 2022 (Filed With SEC on October 25, 2022)

Purchase Agreement, dated August 16, 2022, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 17, 2022)

Registration Rights Agreement, dated August 16, 2022, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 17, 2022)

Form of Certificate of Designation of Series A Convertible Redeemable Preferred Stock Form of Certificate of Designation of Series B Convertible Redeemable Preferred Stock Form of... (Filed With SEC on June 22, 2022)

Description of Registrants Securities (Filed With SEC on March 14, 2022)

Purchase Agreement, dated December 3, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on December 3, 2021)

Registration Rights Agreement, dated December 3, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on December 3, 2021)

Purchase and Sale Agreement, dated July 26, 2021, between the Company and Southern Research (Filed With SEC on August 9, 2021)

Purchase Agreement, dated May 14, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 14, 2021)

Registration Rights Agreement, dated May 14, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 14, 2021)

License Agreement, dated April 14, 2021, between the Company and OyaGen, Inc (Filed With SEC on May 10, 2021)

Description of Registrants Securities (Filed With SEC on March 15, 2021)

Purchase and Sale Agreement, dated March 5, 2021, between Tonix Pharmaceuticals Holding Corp. and the Seller named therein (Filed With SEC on March 15, 2021)

Employment Agreement, dated February 23, 2021, between the Company and Jessica Morris (Filed With SEC on February 26, 2021)

Employment Agreement, dated February 23, 2021, between the Company and Bradley Saenger (Filed With SEC on February 26, 2021)

Placement Agency Agreement, dated February 8, 2021 between the Company and A.G.P./Alliance Global Partners (Filed With SEC on February 9, 2021)

Form of Securities Purchase Agreement, dated February 8, 2021, by and between the Company and the Purchasers thereunder (Filed With SEC on February 9, 2021)

Form of Investor Agreement, dated February 8, 2021, by and between the Company and the Purchasers thereunder (Filed With SEC on February 9, 2021)

Placement Agency Agreement, dated January 11, 2021 between the Company and A.G.P./Alliance Global Partners (Filed With SEC on January 12, 2021)

Form of Securities Purchase Agreement, dated January 11, 2021, by and between the Company and the Purchasers thereunder (Filed With SEC on January 12, 2021)

Purchase and Sale Agreement, dated October 14, 2020 (Filed With SEC on November 9, 2020)

Purchase Agreement, dated September 3, 2020, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 4, 2020)

Registration Rights Agreement, dated September 3, 2020, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 4, 2020)

Purchase and Sale Agreement, dated July 1, 2020 (Filed With SEC on August 10, 2020)

Asset Purchase Agreement, dated June 11, 2020, between the Company and Trigemina, Inc (Filed With SEC on August 10, 2020)

Amended and Restated Exclusive License Agreement, dated June 11, 2020, between the Company and The Board of Trustees of the Leland Stanford Junior University (Filed With SEC on August 10, 2020)

Assignment and Agreement, dated June 11, 2020, between the Company and The Board of Trustees of the Leland Stanford Junior University (Filed With SEC on August 10, 2020)

Placement Agency Agreement, dated July 13, 2020 between the Company and A.G.P./Alliance Global Partners (Filed With SEC on July 14, 2020)

Form of Securities Purchase Agreement, dated July 13, 2020, by and between the Company and the Purchasers thereunder (Filed With SEC on July 14, 2020)

License Agreement, dated May 5, 2020, between Tonix Pharmaceuticals (Canada) Inc. and The Governors of the University of Alberta (Filed With SEC on May 12, 2020)

Research Service Agreement, May 6, 2020, between Tonix Pharmaceuticals (Canada) Inc. and The Governors of the University of Alberta (Filed With SEC on May 12, 2020)

Description of Registrants Securities (Filed With SEC on March 24, 2020)

Research Collaboration Agreement between Tonix Pharmaceutical, Inc. and Southern Research Institute, dated November 7, 2018 (Filed With SEC on March 24, 2020)

Placement Agency Agreement, dated February 28, 2020 between the Company and A.G.P./Alliance Global Partners (Filed With SEC on February 28, 2020)

Form of Securities Purchase Agreement, dated February 28, 2020, by and between the Company and the Purchasers thereunder (Filed With SEC on February 28, 2020)

Form of Underwriting Agreement (Filed With SEC on February 6, 2020)

Form of Warrant (Filed With SEC on February 6, 2020)

Form of Warrant Agency Agreement (Filed With SEC on February 6, 2020)

Form of Warrant (Filed With SEC on November 15, 2019)

Form of Common Warrant (Filed With SEC on November 15, 2019)

Form of Underwriting Agreement (Filed With SEC on November 14, 2019)

Form of Warrant (Filed With SEC on November 14, 2019)

Form of Common Stock Purchase Warrant (Filed With SEC on November 14, 2019)

Form of Warrant Agency Agreement (Filed With SEC on November 14, 2019)

Form of Warrant Agreement (Filed With SEC on November 14, 2019)

Asset Purchase Agreement, dated August 19, 2019, between Tonix Pharmaceuticals Holding Corp. and TRImaran Pharma, Inc (Filed With SEC on November 8, 2019)

First Amended and Restated Exclusive License Agreement, dated August 19, 2019, between Tonix Pharmaceuticals Holding Corp. and Wayne State University (Filed With SEC on November 8, 2019)

Exclusive License Agreement, dated September 16, 2019, between Tonix Pharmaceuticals Holding Corp. and The Trustees of Columbia University in the City of New York (Filed With SEC on November 8, 2019)

Purchase Agreement, dated August 20, 2019, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 23, 2019)

Registration Rights Agreement, dated August 20, 2019, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 23, 2019)

License Agreement, dated May 20, 2019, between Tonix Pharmaceuticals Holding Corp. and The Trustees of Columbia University in the City of New York (Filed With SEC on August 12, 2019)

Form of Underwriting Agreement (Filed With SEC on July 15, 2019)

Form of Underwriting Agreement (Filed With SEC on July 11, 2019)

Second Amendment of Lease and Assignment of Lease (this Amendment) made as of December 6, 2018, by and between 509 Madison Avenue Associates, LP, and Tonix Pharmaceuticals, Inc (Filed With SEC on March 18, 2019)

Underwriting Agreement, dated December 7, 2018, by and between Tonix Pharmaceuticals Holding Corp. and A.G.P./Alliance Global Partners, as representative of the underwriters (Filed With SEC on December 11, 2018)

Form of Warrant Agreement (Filed With SEC on December 3, 2018)

Form of Warrant Agency Agreement between Tonix Pharmaceuticals Holding Corp. and vStock Transfer, LLC (Filed With SEC on December 3, 2018)

Form of Underwriting Agreement (Filed With SEC on December 3, 2018)

Purchase Agreement, dated October 18, 2018, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 24, 2018)

Registration Rights Agreement, dated October 18, 2018, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 24, 2018)

Specimen Common Stock Certificate (Filed With SEC on May 24, 2018)

Purchase Agreement, dated September 28, 2017, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 29, 2017)

Registration Rights Agreement, dated September 28, 2017, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 29, 2017)

Sales Agreement, dated August 1, 2017, by and between Tonix Pharmaceuticals Holding Corp. and Cowen and Company, LLC (Filed With SEC on August 1, 2017)

Underwriting Agreement, dated March 30, 2017, by and between Tonix Pharmaceuticals Holding Corp. and Aegis Capital Corp., as representative of the underwriters named on Schedule 1... (Filed With SEC on March 30, 2017)

UNDERWRITING AGREEMENT (Filed With SEC on October 26, 2016)

WARRANT AGENCY AGREEMENT (Filed With SEC on October 26, 2016)

TONIX PHARMACEUTICALS HOLDING CORP. 5,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 16, 2016)

TONIXPHARMACEUTICALS HOLDING CORP. $15,000,000 COMMONSTOCK SALESAGREEMENT (Filed With SEC on April 28, 2016)

TONIX PHARMACEUTICALS HOLDING CORP. 2,325,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 14, 2015)

LEASE AMENDMENT AND EXPANSION AGREEMENT (Filed With SEC on February 27, 2015)

TONIX PHARMACEUTICALS HOLDING CORP. 4,900,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 4, 2015)

annexI TERMS AND CONDITIONS FOR PURCHASE OF SHARES (Filed With SEC on July 11, 2014)

TONIX PHARMACEUTICALS HOLDING CORP. 657,000 Shares of Common Stock PLACEMENT AGENT AGREEMENT (Filed With SEC on July 11, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on June 3, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 1, 2014)

ASSET PURCHASE AGREEMENT (Filed With SEC on March 21, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 19, 2014)

TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 (Filed With SEC on March 19, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 19, 2014)

TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 (Filed With SEC on March 19, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 14, 2014)

TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 February 11, 2014 (Filed With SEC on February 14, 2014)

TONIX PHARMACEUTICALS HOLDING CORP. 2,898,550 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 24, 2014)

TONIX PHARMACEUTICALS HOLDING CORP. 509 Madison Avenue, Suite 306 New York, New York 10022 October 15, 2013 (Filed With SEC on October 17, 2013)

DEMAND PROMISSORY NOTE (Filed With SEC on August 8, 2013)

TONIX PHARMACEUTICALS HOLDING CORP. ____________ Units Each Unit Consisting of One Share ofCommon Stock and One Series A Warrant to Purchase OneShare of Common Stock UNDERWRITING... (Filed With SEC on July 31, 2013)

TONIX PHARMACEUTICALS HOLDING CORP. ____________ Units Each Unit Consisting of One Share ofCommon Stock and One Series A Warrant to Purchase OneShare of Common Stock UNDERWRITING... (Filed With SEC on July 2, 2013)

TONIX PHARMACEUTICALS HOLDING CORP. ____________ Units Each Unit Consisting of One Share ofCommon Stock and One Series A Warrant to Purchase OneShare of Common Stock UNDERWRITING... (Filed With SEC on June 21, 2013)

TONIX PHARMACEUTICALS HOLDING CORP. ____________ Units Each Unit Consisting of One Share ofCommon Stock and One Series A Warrant to Purchase OneShare of Common Stock UNDERWRITING... (Filed With SEC on June 20, 2013)

TONIXPHARMACEUTICALS HOLDING CORP. WarrantTo Purchase Common Stock (Filed With SEC on June 20, 2013)

[FORMOF UNDERWRITER WARRANT] (Filed With SEC on June 20, 2013)

CLASS A WARRANT (Filed With SEC on December 27, 2012)

TONIX PHARMACEUTICALS HOLDING CORP. (Filed With SEC on December 27, 2012)

AMENDMENT NO. 1 TO THE PURCHASE AGREEMENT,REGISTRATION RIGHTS AGREEMENT AND ESCROW AGREEMENT (Filed With SEC on December 27, 2012)

SUBSCRIPTION AGREEMENT (Filed With SEC on December 5, 2012)

WARRANT TO PURCHASE COMMON STOCK VOID AFTER 5:30 P.M., EASTERN TIME, ON THE EXPIRATION DATE (Filed With SEC on December 5, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 5, 2012)

SUBSCRIPTION AGREEMENT (Filed With SEC on November 14, 2012)

TONIX PHARMACEUTICALS HOLDING CORP. 8% CONVERTIBLE DEBENTURE (Filed With SEC on November 14, 2012)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on October 10, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on April 5, 2012)

FEASIBILITY AND OPTION AGREEMENT (Filed With SEC on April 3, 2012)

Improved Oral Delivery of Cyclobenzaprine– Feasibility Proposal (Filed With SEC on April 3, 2012)

AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on March 30, 2012)

FEASIBILITY AND OPTION AGREEMENT (Filed With SEC on February 3, 2012)

STANDARD FORM OF OFFICE LEASE The Real Estate Board of New York, Inc, (Filed With SEC on February 3, 2012)

SUBSCRIPTIONAGREEMENT (Filed With SEC on January 23, 2012)

CLASS A WARRANT (Filed With SEC on January 23, 2012)

NON-TRANSFERABLE CLASS B WARRANT (Filed With SEC on January 23, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 23, 2012)

Exhibit 10.20 is filed herewith as a PDF reference. (Filed With SEC on December 27, 2011)

TAMANDARE EXPLORATIONS INC. 8% SECURED CONVERTIBLE DEBENTURE $____________New York, New YorkDated as of:October 7, 2011 (Filed With SEC on October 14, 2011)

_________________________ SUBSCRIPTION AGREEMENT _________________________ (Filed With SEC on October 14, 2011)

SHARE EXCHANGE AGREEMENT by and among Tonix Pharmaceuticals, Inc. (Tonix) and the Shareholders of Tonix, on the one hand; and Tamandare Explorations Inc. (Pubco), a Nevada... (Filed With SEC on October 14, 2011)

PLEDGE AND SECURITY AGREEMENT (Filed With SEC on October 14, 2011)

SUBSIDIARY GUARANTY (Filed With SEC on October 14, 2011)

CONSULTING AGREEMENT (Filed With SEC on October 14, 2011)

BACKGROUND (Filed With SEC on October 14, 2011)

FINANCIAL PUBLIC RELATIONS LETTER OF AGREEMENT FOR TONIX Pharmaceuticals, Inc. (Filed With SEC on October 14, 2011)

FEASIBILITY AND OPTION AGREEMENT (Filed With SEC on October 14, 2011)

Silicon ValleySan AntonioNew YorkTorontoLondonParisFrankfurtTokyoChennai (Filed With SEC on October 14, 2011)

API SUPPLY AND DEVELOPMENT AGREEMENT (TONIX) (Filed With SEC on October 14, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on October 14, 2011)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on October 14, 2011)

Category

Industry

Companies

Contracts

Tonix Pharmaceuticals Holding Corp. Contracts & Agreements